Inflamed phenotype of splenic marginal zone B-cell lymphomas with expression of PD-L1 by intratumoral monocytes/macrophages and dendritic cells

Ítems similars

• Pre-clinical blocking of PD-L1 molecule, which expression is down regulated by NF-κB, JAK1/JAK2 and BTK inhibitors, induces regression of activated B-cell lymphoma
  per: Christelle Vincent-Fabert, et al.
  Publicat: (2019-08-01)
• Pre-clinical blocking of PD-L1 molecule, which expression is down regulated by NF-κB, JAK1/JAK2 and BTK inhibitors, induces regression of activated B-cell lymphoma
  per: Vincent-Fabert, Christelle, et al.
  Publicat: (2019)
• Continuous MYD88 Activation Is Associated With Expansion and Then Transformation of IgM Differentiating Plasma Cells
  per: Ouk, Catherine, et al.
  Publicat: (2021)
• Uncovering regulatory B‐cell features associated with regulatory T‐cell expansion and global T‐cell exhaustion in Waldenström macroglobulinemia Myd88L252P‐like lymphoplasmacytic lymphomas
  per: Quentin Lemasson, et al.
  Publicat: (2025-10-01)
• Langerin+CD8+ Dendritic Cells in the Splenic Marginal Zone: Not So Marginal After All
  per: Ronald A. Backer, et al.
  Publicat: (2019-04-01)